drugsScienceThe Crackdown on Compounded GLP-1 Meds Has BegunScienceA Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t CelebratingThe Big StoryAfter Shark Tank, Mark Cuban Just Wants to Break Shit—Especially the Prescription Drug IndustryScienceThe Uncertain Path Forward for Psychedelic MedicineScienceSupplements Companies Are Cashing In on the Ozempic WaveScienceHow Do You Get Drugs to the Brain? Maybe Try a ParasiteScienceThe FDA Just Rejected a Bid for MDMA to Treat PTSDGearSemaglutide for the PeopleScienceThe Case for MDMA’s Approval Is Riddled With ProblemsThe Big StoryInside the Biggest FBI Sting Operation in HistorySecurityEventbrite Promoted Illegal Opioid Sales to People Searching for Addiction Recovery HelpScienceThe Next Generation of Cancer Drugs Will Be Made in SpaceScienceThey Had PTSD. A Psychedelic Called Ibogaine Helped Them Get BetterScienceOzempic Could Also Help You Drink Less AlcoholScienceThe First Crispr Medicine Just Got ApprovedScienceWegovy Slashes the Risk of Heart Attack and Stroke in a Landmark TrialScienceThe FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic RivalScienceCalifornia Nixes a Bill to Decriminalize Plant-Based PsychedelicsScienceCovid Boosters Can’t Outpace New Mutations. Here’s Why They Still WorkScienceOzempic and Wegovy Can Also Protect Your HeartCultureAdderall Shortages Are Dragging On—Can Video Games Help?ScienceEveryone Was Wrong About AntipsychoticsScienceThe First Pill for Postpartum Depression Is Almost HereScienceTicks and the Diseases They Carry Are Spreading. Can This Drug Stamp Them Out?More Stories
